Dr. Andrew Shorr, MD

• Pulmonary Disease

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Nat'l Capital Consortium

  Residency Hospital

• Walter Reed Army Medical Center

  Residency Hospital

• Virginia Commonwealth University School Of Medicine

  Medical School, 1994

• A risk score for identifying methicillin-resistantStaphylococcus aureusin patients presenting to the hospital with pneumonia, 2013-06-06

• Going Viral-RSV as the Neglected Adult Respiratory Virus, 2022-11-11

• Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study, 2014-11-21

• Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients, 2013-02-28

• Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study, 2010-06-03

• Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation, 2007-08-31

• 1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018, 2021-12-04

• Morbidity and cost burden of methicillin-resistantStaphylococcus aureusin early onset ventilator-associated pneumonia, 2006-06-29

• Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning, 2008-11-25

• Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation, 2009-06-19

• Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study, 2008-08-18

• Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections, 2012-07-11

• Protein C: a potential biomarker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated), 2008-04-04

• Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis, 2011-10-25

• Outcomes associated with bacteremia in the setting of methicillin-resistantStaphylococcus aureuspneumonia: a retrospective cohort study, 2015-09-03

• Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistantStaphylococcus aureus, 2014-07-22

• Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board, 2019-10-08

• Predictors of Clinical Success in the Treatment of Patients with Methicillin-ResistantStaphylococcus aureus(MRSA) Nosocomial Pneumonia (NP), 2015-07-21

• Respiratory Viruses in Nosocomial Pneumonia: An Evolving Paradigm, 2023-07-31

• Timing of antibiotic therapy in the ICU, 2021-10-15

• Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data, 2014-06-05

• Multidrug resistance, inappropriate empiric therapy, and hospital mortality inAcinetobacter baumanniipneumonia and sepsis, 2016-07-11

• 1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019, 2021-12-04

• Application of a population-based severity scoring system to individual patients results in frequent misclassification, 2005-08-09

• Imipenem resistance ofPseudomonasin pneumonia: a systematic literature review, 2010-08-26

• Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study, 2008-04-28

• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused byCandida albicans: a multivariate analysis of factors associated with improved outcome, 2011-09-30

• Candidemia on presentation to the hospital: development and validation of a risk score, 2009-09-29

• Hospital readmission withClostridium difficileinfection as a secondary diagnosis is associated with worsened outcomes and greater revenue loss relative to principal diagnosis A retrospective cohort study, 2018-09-07

• Statistics on steroids: How recognizing competing risks gets us closer to the truth about COVID-19-associated VAP, 2022-12-21

• Increase in AdultClostridium difficile-related Hospitalizations and Case-Fatality Rate, United States, 2000-2005 C. difficile-related Hospitalizations, United States, 2008-06-01

• Predictors of hospital mortality among septic ICU patients withAcinetobacter spp.bacteremia: a cohort study, 2014-10-30

• Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome, 2006-06-15

• Anemia, costs and mortality in Chronic Obstructive Pulmonary Disease, 2006-10-16

• Critical Parameters for the Development of Novel Therapies for Severe and Resistant Infections-A Case Study on CAL02, a Non-Traditional Broad-Spectrum Anti-Virulence Drug, 2020-02-21

• Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019, 2022-12-09

• RecurrentClostridium difficileinfection among Medicare patients in nursing homes A population-based cohort study, 2017-03-10

• Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study, 2014-10-29

• Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated), 2010-12-21

• Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study, 2007-06-06